In a transition that will take effect on March 1, 2016, James Bradner, associate professor of medicine at Brigham and Women’s Hospital and Dana Farber Cancer Institute, will take over as president of the Cambridge-based Novartis Institutes for BioMedical Research.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?